Tony Simon

Tony Simon is a cognitive neuroscientist with over 30 years of experience in the field, along with 20 years as a federally-funded principal investigator, focused on developing treatments and biomarkers for neurobehavioral, neuromotor, and neurocognitive challenges.

He is the Co-Founder, CEO, and CSO of Cognivive, a company that translates scientific and clinical evidence into home-use, contactless neuro-rehabilitation treatments delivered through virtual reality treatment games.

Recently, Cognivive was acquired by REACT Neuro, where Tony Simon serves as the Chief Science Translation Officer, continuing the mission of advancing neuro-rehabilitation treatments.

His expertise spans areas such as translational cognitive neuroscience research, digital health commercialization, medical device regulation, and digital medicine reimbursement.

Tony Simon's research specialties include clinical research, cognitive neuroscience, brain and cognitive development, neuroimaging, and the simulation of human and artificial intelligence.

He has a diverse educational background with Ph.D. studies in Developmental Psychology at The University of Sheffield, and postdoc studies in Psychology & Computer Science at Carnegie Mellon University, among others.

Throughout his career, Tony Simon held various positions at prestigious organizations including the University of California, Davis - School of Medicine, REACT Neuro, and several editorial roles in scientific publications.

His experience covers teaching, grant writing and reviewing, quality management processes, investment and diligence, and an in-depth understanding of the scientific method.